'Warm-base' network

ECRAID-Base has established a ‘warm-base’ clinical research network for infectious diseases. The fully operational ‘warm-base’ network has the capacity and capability to:

  • directly enrol patients with infectious diseases to generate evidence to support the testing and development of new diagnostic, preventive and/or therapeutic strategies and therapies;
  • conduct a broad range of rigorous clinical studies efficiently and rapidly;
  • function as a platform for a rapid research response in the face of serious infectious disease outbreaks.

Our network

This clinical research network includes primary care settings, hospital settings (including emergency rooms and intensive care units), pediatric care settings, and laboratories. These networks are currently functioning as the clinical research base for several studies within PREPARE, COMBACTE, RECOVER, and VALUE-Dx.

ECRAID-Base focuses on the efficient and effective development and implementation of clinical interventions against infectious diseases by generating rigorous evidence to improve the diagnosis, prevention and treatment of infections and to respond to infectious disease threats rapidly.

The network will provide an efficient European infrastructure capable of performing all aspects of clinical studies, from design to dissemination. It will function as the backbone of clinical research activities in the field of infectious diseases by world-leading ID experts. Key design principles built into the network’s organisation and operations will ensure the delivery of a rapid and coordinated research response to public health emergencies that represent an imminent or immediate threat to the health and security of people living in Europe.
 
Encompassing over 2,000 sites in more than 40 European countries, six perpetual clinical studies are at the heart of ECRAID-Base. These studies will mature towards adaptive platform trials with capability to rapidly respond to public health threats.